Laatikainen L, Kohner E M, Khoury D, Blach R K
Br J Ophthalmol. 1977 Dec;61(12):741-53. doi: 10.1136/bjo.61.12.741.
A randomised controlled study of photocoagulation compared with no treatment in central retinal vein occlusion is reported. Forty-eight patients were allocated into treated and control groups by a random procedure 3 months after their first visual symptoms. For the analysis they were subdivided into (1) ischaemic type, and (2) hyperpermeability-response macular-oedema type of central retinal vein occlusion. In neither group did treatment confer benefit as far as visual acuity was concerned. However, iris, disc, and retinal neovascularisation improved after treatment in the ischaemic group. In addition none of the treated patients progressed to neovascular glaucoma. Macular-oedema improved in treated patients with the hyperpermeability response, but the visual field was affected and atrophic changes at the macular precluded visual improvement. It is concluded that photocoagulation should be used only to prevent complications in the ischaemic type of central retinal vein occlusion. It does not appear to be of value in the hyperpermeability group.
本文报道了一项关于视网膜中央静脉阻塞光凝治疗与不治疗的随机对照研究。48例患者在首次出现视觉症状3个月后,通过随机程序分为治疗组和对照组。为了进行分析,他们被进一步细分为:(1)缺血型,以及(2)视网膜中央静脉阻塞的高渗透性反应性黄斑水肿型。就视力而言,两组患者接受治疗均未获益。然而,缺血组患者治疗后虹膜、视盘和视网膜新生血管有所改善。此外,接受治疗的患者均未进展为新生血管性青光眼。高渗透性反应的治疗患者黄斑水肿有所改善,但视野受到影响,黄斑处的萎缩性改变妨碍了视力的提高。结论是,光凝治疗仅应用于预防缺血型视网膜中央静脉阻塞的并发症。在高渗透性组中似乎没有价值。